Home › Compare › AVNBF vs JNJ

AVNBF vs JNJ: Dividend Comparison 2026

AVNBF yields 0.99% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AVNBF wins by $336.00 in total portfolio value
10 years
AVNBF
AVNBF
● Live price
0.99%
Share price
$24.70
Annual div
$0.25
5Y div CAGR
-15.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.4K
Annual income
$19.98
Full AVNBF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — AVNBF vs JNJ

📍 AVNBF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAVNBFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AVNBF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
AVNBF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AVNBF
Annual income on $10K today (after 15% tax)
$84.44/yr
After 10yr DRIP, annual income (after tax)
$16.98/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $686.63/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AVNBF + JNJ for your $10,000?

AVNBF: 50%JNJ: 50%
100% JNJ50/50100% AVNBF
Portfolio after 10yr
$20.2K
Annual income
$423.88/yr
Blended yield
2.10%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

AVNBF
Analyst Ratings
1
Buy
2
Hold
Consensus: Hold
Altman Z
4.2
Piotroski
7/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AVNBF buys
0
JNJ buys
0
No recent congressional trades found for AVNBF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAVNBFJNJ
Forward yield0.99%3.36% ✓
Annual dividend / share$0.25$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR-15.1%5.8% ✓
Portfolio after 10y$20.4K ✓$20.0K
Annual income after 10y$19.98$827.78 ✓
Total dividends collected$457.00 ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: AVNBF vs JNJ ($10,000, DRIP)

YearAVNBF PortfolioAVNBF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,784$84.34$10,676$355.77+$108.00 → AVNBF
2$11,611$72.17$11,407$389.39+$204.00 → AVNBF
3$12,486$61.65$12,198$426.53+$288.00 → AVNBF
4$13,412$52.60$13,056$467.62+$356.00 → AVNBF
5$14,396$44.84$13,987$513.12+$409.00 → AVNBF
6$15,442$38.18$14,998$563.56+$444.00 → AVNBF
7$16,556$32.50$16,098$619.52+$458.00 → AVNBF
8$17,742$27.65$17,295$681.69+$447.00 → AVNBF
9$19,008$23.51$18,599$750.82+$409.00 → AVNBF
10$20,358$19.98$20,022$827.78+$336.00 → AVNBF

AVNBF vs JNJ: Complete Analysis 2026

AVNBF — Stock

Avon Technologies Plc engages in the manufacture and design of respiratory protection products for defense and industrial users. The firm also offers polymer based products for the dairy and defense industries. It operates through the Respiratory Protection and Head Protection segments. The company was founded in 1885 and is headquartered in Melksham, the United Kingdom.

Full AVNBF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this AVNBF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AVNBF vs SCHDAVNBF vs JEPIAVNBF vs OAVNBF vs KOAVNBF vs MAINAVNBF vs ABBVAVNBF vs MRKAVNBF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.